Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-3258
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations ; volume:81 ; number:1 ; day:18 ; month:1 ; year:2023 ; pages:1-10 ; date:12.2023
Archives of public health ; 81, Heft 1 (18.1.2023), 1-10, 12.2023
- Creator
-
Todesco, Beatrice
Ostuzzi, Giovanni
Gastaldon, Chiara
Papola, Davide
Barbui, Corrado
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13690-022-01014-x
- URN
-
urn:nbn:de:101:1-2023032609130702086310
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
21.05.2412, 3:44 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Todesco, Beatrice
- Ostuzzi, Giovanni
- Gastaldon, Chiara
- Papola, Davide
- Barbui, Corrado
- SpringerLink (Online service)
Other Objects (12)
Revising the WHO Essential Medicines List for paediatric rheumatology
Revising the WHO Essential Medicines List for paediatric rheumatology update
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Enabling access to new WHO essential medicines: the case for nicotine replacement therapies
Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
Biologic medicine inclusion in 138 national essential medicines lists
Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil
Revising the WHO Essential Medicines List for paediatric rheumatology
Revising the WHO Essential Medicines List for paediatric rheumatology update
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Enabling access to new WHO essential medicines: the case for nicotine replacement therapies
Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
Biologic medicine inclusion in 138 national essential medicines lists
Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil
Revising the WHO Essential Medicines List for paediatric rheumatology
Revising the WHO Essential Medicines List for paediatric rheumatology update
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Enabling access to new WHO essential medicines: the case for nicotine replacement therapies
Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology
Improving quality of essential medicines : a biowaiver approach
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
Biologic medicine inclusion in 138 national essential medicines lists